Dopamine agonist vs placebo
Risk for at least one adverse event per patient · patients with the treatment of cocaine dependence
Any dopamine agonist showed no clear difference in adverse events as N of participants with at least one adverse event compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.27 [0.66, 2.44]7 studies · 252 participantsModerate